Side effects are not common with this medicine, but some may occur. Minor discomforts, such as dizziness, lightheadedness, flushing, headache, and nausea, usually go away as the body adjusts to the drug and do not require medical treatment unless they persist or they are bothersome.
If any of the following side effects occur, the prescribing physician should be notified as soon as possible:
Other side effects may occur. Anyone who has unusual symptoms after taking calcium blockers should contact the prescribing physician.
Calcium channel blockers may interact with a number of other medications. When this happens, the effects of one or both of the drugs may change or the risk of side effects may increase. Anyone who takes calcium channel blockers should not take any other prescription or non-prescription (over-the-counter) medicines without first checking with the prescribing physician. Substances that may interact with calcium channel blockers include:
The above list does not include every drug that may interact with calcium channel blockers. The prescribing physician or pharmacist will advise as to whether combining calcium channel blockers with any other prescription or nonprescription (over-the-counter) medication is appropriate or not.
Calcium channel blockers are available only with a physician's prescription and are sold in tablet, capsule, and injectable forms. Some commonly used calcium channel blockers include amlopidine (Norvasc), diltiazem (Cardizem), isradipine (DynaCirc), nifedipine (Adalat, Procardia), nicardipine (Cardene), and vera-pamil (Calan, Isoptin, Verelan).
The recommended dosage depends on the type, strength, and form of calcium channel blocker and the condition for which it is prescribed. Correct dosage is determined by the prescribing physician and further information can be obtained from the pharmacist.
Calcium channel blockers should be taken as directed. Larger or more frequent doses should not be taken, nor should doses be missed. This medicine may take several weeks to noticeably lower blood pressure. The patient taking calcium channel blockers should keep taking the medicine, to give it time to work. Once it begins to work and symptoms improve, it should continue to be taken as prescribed.
This medicine should not be discontinued without checking with the prescribing physician. Some conditions may worsen when patients stop taking calcium channel blockers abruptly. The prescribing physician will advise as to how to gradually taper down before stopping the medication completely.
A report from the European Cardiology Society in 2000 found that patients taking certain calcium channel blockers had a 27% greater risk of heart attack, and a 26% greater risk of heart failure than patients taking other high blood pressure medicines. However, there are many patients affected by conditions that still make calcium channel blockers the best choice for them. The patient should discuss this issue with the prescribing physician.
The expected result of taking a calcium channel blocker is to either correct abnormal heart rhythms, return blood pressure to normal, or relieve chest pain.
Beers, Mark H. and Robert Berkow, eds. The Merck Manual of Diagnosis and Therapy. 17th ed. Whitehouse Station, NJ: Merck and Company, Inc., 1999.
Zoler, Mitchel L."Drug Update: Calcium Channel Blockers For Hypertension." Family Practice News (April 1, 2000): 53.
"The Pressure's On: A Hypertension Drug Taken by 28 Million People is Under Scrutiny. What Are the Other Options? (Calcium Channel Blockers)." Time (September 11,2000): 126.
National Heart, Lung and Blood Institute. <http://www.nhlbi.nih.gov>.
Deanna M. Swartout-Corbeil, R.N.
|
|
Author Info: Deanna M. Swartout-Corbeil R.N., The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Medicine, 2002 |